Q/C Technologies, Inc. Available-for-sale Securities
Q/C Technologies, Inc. (QCLS) had Available-for-sale Securities of $8.68 million as of 2018-03-31, per its 10-Q filed 2018-07-13.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2018-07-13
- 2018-03-31: Available-for-sale Securities $8.68M.
- 2017-12-31: Available-for-sale Securities $5.01M.
- 2017-09-30: Available-for-sale Securities $10.18K.
- 2017-06-30: Available-for-sale Securities $1.01M.
| Period end | Available-for-sale Securities |
|---|---|
| 2018-03-31 | $8.68M 10-Q · filed 2018-07-13 |
| 2017-12-31 | $5.01M 10-K/A · filed 2018-07-13 |
| 2017-09-30 | $10.18K 10-Q/A · filed 2018-07-13 |
| 2017-06-30 | $1.01M 10-Q/A · filed 2018-07-13 |
| 2017-03-31 | $157.47K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $50.00K 10-Q/A · filed 2018-07-13 |
| 2016-09-30 | $599.94K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $1.55M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $2.44M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $4.03M 10-K · filed 2017-04-11 |
| 2015-09-30 | $5.23M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $6.42M 10-Q · filed 2015-08-18 |
| 2015-03-31 | $8.06M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $9.26M 10-K · filed 2016-03-30 |
| 2014-09-30 | $10.21M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $11.44M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $12.50M 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |